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ABSTRACT 
Bioprinting is an additive tissue manufacturing process in which cells are stacked in a 
layer by layer process. Progress in bioprinting techniques have advanced the potential in 
various medical disciplines such as printed tissue, organs, and bone structures for 
implantation. Due to the wide array of variations in terms of application there can be a 
lot of confusion as to what the best method would be to print a structure. This review will 
describe key factors to the printing process such as bioink selection, printer 
configurations as well as post-print stabilization methods. Greater understanding of 
available technologies can dramatically improve print quality, function, and ease. 
 
KEYWORDS: 3D Printing, bioink, cell viability, fused deposition modeling, organ 
transplant 
 
INTRODUCTION  
Organ transplants are a costly procedure1 in the world of healthcare due to the 
nationwide decrease in organ donations.2 This deprivation has triggered the search for 
solutions to alleviate the gap between patient wait time and organ availability. The need 
for organ transplants potentially can be remedied with innovative research in pluripotent 
stem cells engineering, or bioprinting.3 Understanding the variety of technologies 
available within the domain of pluripotent stem cell printing is crucial to be able to get 
an effective benefit from their use. Three-dimensional (3D) bioprinting is one of the 
fastest growing pioneer fields of science4 which utilizes aspects from both engineering 
and biology to merge the two disciplines. Bioprinting first began out of the mechanical 
engineering realm of 3D printing. 3D printing is an additive manufacturing (AM) process 
in which a digital design is fabricated layer by layer into a 3D structure.4  
3D printers are being employed in more than just the engineering world and are crossing 
disciplines with a number of different fields, including the medical sector.5 
Advancements in pluripotent stem cell research have allowed for the printing of an array 
of biological structures ranging from the simple creation of small tissues and blood 
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vessels 6 to larger organ structures and even bone.7 Researchers still face the problem of 
printing large highly complex structures, such as lungs. There are also problems with cell 
viability and long-term functionality of printed structures that need to be addressed. One 
general solution to some of these challenges is the specialization of printing equipment 
and techniques. This review article will discuss the various techniques that are utilized in 
bioprinting, specifically (1) three different printing methodologies: inkjet-based, laser, 
and microextrusion. Finally, some techniques for (2) post-print stabilization and viability 
will be discussed.  
 
PRINTING METHODOLOGY 
Many types of printers are available for the purpose of bioprinting. The three most 
common types used by researchers are inkjet-based printer, laser based printers, and 
microextrusion. These printers can vary in factors such as their mechanical design, cost, 
precision and speed and viability of biological structures. Each printer also has several 
specific advantages and disadvantages depending on the intended output of the 
structure.  
Inkjet-based printing  
Inkjet-based printers perform by depositing controlled volumes of bioink to 
predetermined locations.4 Inkjet printers were initially intended for commercial use but 
have been modified by trading in the ink cartridge with biological material, and the paper 
for an electronic elevator stage that moves across the x, y, and z- axis. Now inkjet printers 
are the most popular printers used bioprinting. These reconfigured printers operate 
using two types of drop injection: thermal and acoustic forces. 
Thermal inkjet printers electrically heat an extrusion nozzle or print head to hundreds of 
degrees (200 °C -300 °C).8 Heating then produces pulses of pressure which force droplets 
from the nozzle.8 The advantages of the thermal inkjet printers are that they are low in 
cost and widely available. Thermal inkjets also have a very high printing speed.9 This is 
due to their simple design and inexpensive parts. However, these printers can have a 
number of draw backs such as low droplet directionality, unequal droplet size, and cell 
exposure to thermal and mechanical stress.4 Acoustic inkjet printers generate sound 
waves within the printer head by utilizing a piezoelectric crystal.9 The sudden voltage 
induces a sudden change in shape generating pressure to move bioink droplets from the 
nozzle.8  
The additional advantages of this technique are that the droplet size is more uniform 
during extrusion.4 This gives printed structures a higher surface resolution. Another 
advantage of the inkjet printer is that it can generally be found at a very low cost. Inkjet 
printers are also compatible with a broad range of organic and inorganic materials and 
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hydrogels.6 The fast speed of the printer is also a valuable trait that some researchers 
have taken advantage of in the regeneration of skin and cartilage in situ.10 The printer 
can deposit cellular material directly into wounded skin and cartilage to seal or stop the 
spread of damage. Despite this speed advantage, there are some disadvantages to inkjet 
printing. These printers are subject to frequent nozzle clogging during deposition.4 When 
this happens the droplet size from extruder becomes nonuniform.  
Laser printing  
Laser-based printing (LAB) consists of three main components: a pulse laser source, 
beam delivery optics, and a coated target called the ribbon opposite to the substrate 
receiving the target.11 This system is known as laser-induced forward transfer (LIFT) in 
which laser pulses are fired at a cell containing absorbing layer that make high pressure 
bubbles propel toward a substrate.4 The pulse laser serves as the power source in this 
configuration, and beam optics are the way the laser’s strength, position and optical 
focus are controlled. The deposition of the substrate is indirect. Although laser printers 
are less commonly used than inkjet and microextrusion9, they are still a valuable method 
for tissue and organ printing. Since LIFT based printers run on light based manipulation, 
there is no chance for nozzle clogging seen in other printer configurations. 11 This lessens 
stoppable time and the need for “re-running” during print deposition. Laser based 
printers can deposit cells at a wide range (1-300 mPa/s) of viscosities. A test of varying 
viscosities found that quality of surface resolution increased in mammalian cells.9, 12 
Despite these advantages, LAB have several drawbacks. LAB printers are generally more 
expensive than inkjet and microextrusion printers due to their complex designs. Laser 
systems configured to printing systems make up a major of costs on their own, but 
organic ribbon coats are also costly because they are difficult to manufacture.13 Another 
drawback is that start-up (pre-heating and ribbon substrate prep)  to completion time is 
time consuming. There is also the problem of contamination from metallic residue left 
behind from the absorbing layer. However, researchers seeking to utilize more sensitive 
materials found that use of non-metallic absorbing layers reduced contaminates.14 
Complete removal of an absorbing layer could also be a potential solution in the 
reduction of residue.  
Microextrusion printing   
Microextrusion printing robotically controls the extrusion of materials onto a substrate 
surface using pressure.15 Bioinks are inserted into a dispensing syringe or tube and then 
forced out of the nozzle either by a piston or a screw driven mechanism.16 Unlike inkjet 
and laser based printing, microextrusion does not dispense bioink in small droplets, but 
rather in large hydrogel filaments. Screw-based extrusion coils the filament in a 
downward motion out of the dispenser, this system works better at dispensing hydrogels 
with higher viscosities.17-18  Piston driven extrusion compresses the bioink down the tube 
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or syringe9. A test of print resolution concluded that this manner of printing offers better 
spatial control then screw-based extrusion and reduced force output,15 providing more 
control to overall flow. The general cost of an microextrusion printer is in the affordable 
range (Table 1), as these printers are the most common type of printing method for the 
purpose of 3D cell laden structures.   
The major drawback of microextrusion printing is that the process is very slow. The 
viability of the cell is also lower in extrusion printing compared to LIFT and inkjet printing. 
This is most likely due to the stress and pressure from the piston driver that the cells are 
exposed to.9 Cell viability for microextrusion is lower than inkjet-based bioprinting.9 
The advantages of microextrusion include their ability to deposit very high cell densities 
(Table 1). This is an important benefit as it allows for larger and thicker cell filaments to 
be made which can increase the range of possible bioinks that can be extruded. The 
bioink can be specifically printed as spheroids. It has been shown that self-assembling 
spheroids accelerate tissue organization and have the potential to form complex 
structures.19 This also increases the surface resolution of the structure, so the surface is 
smoother than inkjet and laser printing. (Table 1)  
 
Table 1. Comparison of Common 3D Printer Configurations for Bioprinting 
 BIOPRINTER TYPE  
 Inkjet-Based 
Printing 
Laser 
Printing 
Microextrusion  References  
EXTRUSION 
PROCESS 
Air bubble 
expansion via 
thermal resistor 
or transducer 
Laser induced 
forward 
transfer 
Pressure 
generator 
concentrated 
valve. 
3-4 
MATERIAL 
COMPATIBILITY   
Broad Range Medium 
Range  
Very Broad 
range 
9, 12 
PRINT SPEED Fast Medium Slow 9, 20 
DROPLET SIZE  50–300 mm >20 microm 100 microm–1 
mm 
3 
SPATIAL 
RESOLUTION  
Medium Medium High 6, 11 
CELL VIABILITY  >85% 40-80% >95% 7, 12 
GENERAL 
PRINTER COST  
Low High Medium 17 
Table 1 
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3D STRUCTURE AND VIABILTY  
Sufficient surface resolution is important during the printing process of a design, but 
resolution does not matter if the structure does not last. Newly bioprinted models also 
require time for cells to grow and develop connections with neighboring cells around 
them.5 Researchers exercise a number of post-printing techniques to elongate cell 
viability time. These techniques can involve building support structures or immersing the 
structure in a solution. Hydrophilic plastic support structures can be built to confine 
injected materials in an immiscible gel allowing for increased duration and strength of 
printed structure.21 Alternating the method deposition can also change viability. 
Researchers testing optimal scaffolding structures utilized fusion based deposition 
systems to print bone.7 Fusion based deposition is an alternative inkjet printing system 
that uses more than one nozzle.  
Newly printed structures can also be submerged in a solution to prompt growth of cell. 
Researcher found that injecting packed micelle lipids into semi-solid organogels were 
able to self-heal,18 signifying that printing within this gel solution helps stability. This 
method is beneficial when support structures cannot be created for soft structures like 
skin tissue. The size of the print determines the type of modification needed. Generally 
larger prints have larger droplet volume and require more manipulation and time to 
prolong cell life and establish extracellular connection.  Droplet volume is reduced when 
concentration of carboxylated agarose is increased,20 improving print quality in both bulk 
and fine printed materials for several weeks. 
 
CONCLUSION 
Background knowledge of the variety of equipment available in bioprinting will help 
increase success in printing, especially for highly specified structures. Initial factors to 
take into consideration include the printer configuration and the standard of bioink the 
printer can accept. Injection design is also a crucial factor that vary in droplet size, cell 
dispensation, and ink compatibility. Post print modification are made to elongate cell/ 
tissue viability as well as simulate growth. Improving bioprinting techniques will raise the 
quality of printed tissues and organs which have the potential to be used in number of 
medical disciplines. One of the many end goals of bioprinting technology is to create a 
more patient-specific approach to healthcare. This would be seen in situations such as 
organ transplants where patient wait time will be reduced, because organs can be 
created on a needed basis. One potential direction for further research may be the 
complete removal of an absorbance layer within LIFT printing. This could potentially be 
a solution to metallic contamination in cells. 
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